TransMedics Group Inc (TMDX)

136.78 -0.73%

TransMedics Group Inc (TMDX) is currently trading at $136.78. This represents a loss of 0.73% from the previous session. With a market capitalization of $4.80B, TMDX is a key component of the Health Care sector. Investors looking to trade TMDX should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade TMDX commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, TransMedics Group Inc (TMDX) shows a bearish trend. Analysts are watching the 144.50 level closely.

Fundamentals
Mkt Cap4.80B
P/E Ratio57.3300
Volume302,119
Others Watching (By Market Cap)
BMRN
Biomarin Pharma $62.05
-0.92% EXEL
Exelixis Inc $45.64
+1.11% RNA
Avidity Bioscie $72.72
-0.03% BAX
Baxter Internat $20.56
-0.41% EHC
Encompass Healt $104.65
-0.18%
60-Day Technical Chart
Advanced Charting

Need more indicators for TMDX? Use the world's #1 platform.

Open TMDX on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $137
Metric TMDX
-0.73% 		PLTR
+2.92% 		WDAY
-3.70% 		MSTR
+5.72%
Price $136.78 $132.72 $125.61 $131.72
Mkt Cap $4.80B $314.40B $33.06B $41.94B
- View → View → View →
Latest Headlines
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates Zacks Investment Research • Feb 25, 2026 TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says MarketBeat • Feb 25, 2026 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire • Feb 20, 2026 TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook TechStock² • Feb 25, 2026 TMDX Analyst Rating Update: Piper Sandler Raises Price Target | GuruFocus • Feb 25, 2026
● Gemini Agentic AI Analyst Insight for TMDX
Market Education
View All Articles →
External Research